Protriptyline and Clorgyline: Interaction Details

Brand names
Protriptyline
Vivactil
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Clorgyline

We don't have a drug information page for Clorgyline yet. Have a question about Clorgyline? Ask a pharmacist, free →

What Happens When You Take Protriptyline With Clorgyline

What can happen when they are taken together (rated Contraindicated)

, seizures, or (hypertension, hyperthermia, myoclonus, mental status changes)

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Taking a TCA together with an has led to hyperpyrexia, convulsions, and fatalities. Reports also link the combined use of and to serotonin syndrome.121121

This uncommon but potentially lethal condition arises from excessive stimulation and presents with hypertension, hyperthermia, myoclonus, and altered mental status.10 For this reason, TCAs and MAOIs should generally not be given together, as is in most situations. When concurrent use cannot be avoided, large doses should be avoided, only oral TCAs should be used, imipramine, clomipramine, desipramine, and tranylcypromine should be avoided, and patients should be monitored closely.615

The Protriptyline and Clorgyline Interaction, Explained

These two medicines should not be taken together. Protriptyline (Vivactil) and clorgyline both raise brain chemicals like and norepinephrine, but in different ways. Combined, they can overstimulate the nervous system. This can cause , with high blood pressure, high fever, muscle jerking, and confusion. Seizures are also possible, and in rare cases it can be life-threatening. Symptoms may not show up right away.

The listed evidence is mostly theoretical, but the warning is firm. Never start or stop either medicine on your own. If you take one and are prescribed the other, talk with your pharmacist or doctor. Your care team can plan a safe switch with the right waiting time between them.

combination (TCA + ). Protriptyline inhibits norepinephrine (and some ) reuptake, while clorgyline irreversibly inhibits MAO-A, so monoamines accumulate. Net effect is increased and noradrenergic activity, with risk of , hyperpyrexia, seizures, and death. Onset is delayed. Evidence is rated theoretical, with case reports for the TCA/MAOI class.

  • Protriptyline is not a , so no activation issue changes the direction.
  • Clorgyline to protriptyline: wait at least 14 days after stopping clorgyline.
  • Protriptyline to clorgyline: no set washout is defined, but taper the TCA before starting the MAOI.
  • If is unavoidable: avoid large doses, use oral only, and monitor closely for hypertension, hyperthermia, myoclonus, and mental status changes.

See the 24 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Protriptyline and Clorgyline Interact

The likely mechanism

Altered catecholamine uptake and

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Protriptyline and Clorgyline Interaction

Care teams generally avoid this combination. If you are switching from one to the other, the timing matters.

  • If moving from clorgyline to protriptyline, your team will have you wait at least 14 days after the last clorgyline dose.
  • If moving from protriptyline to clorgyline, there is no set waiting period, but your team will likely lower the protriptyline dose gradually first.
  • Do not stop or change either medicine on your own.
  • Tell your pharmacist and doctor about every medicine and supplement you take.
  • Seek urgent care for fever, stiff or jerking muscles, severe headache, agitation, confusion, or a seizure.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Protriptyline or Clorgyline need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

8 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: VIVACTIL Tablets, protriptyline hydrochloride tablets, USP

    In the past, the of () and (TCAs) was regarded as an absolute contraindication, and manufacturers still list it that way.22 Excitation, hyperpyrexia, convulsions, and possibly death have been reported with the combination.345678 The mechanism may involve combined of catecholamine reuptake in the central nervous system and inhibition of catecholamine .9

  2. Report 2 · Study title

    Possible development of the serotonin syndrome in man

    Giving a TCA after therapy may lead to . In a double-blind, crossover study of clorgyline and clomipramine for obsessive-compulsive disorder, two subjects had severe reactions typical of serotonin syndrome.

    Patients had been treated with clorgyline, then underwent a washout of about four weeks, and then received clomipramine. After the first 100 mg dose of clomipramine, one patient developed coarse myoclonic jerking in both legs, hyperreflexia, diaphoresis, and .

    A second patient had a similar reaction after the first dose, with upper motor neuron symptoms, myoclonic movements, and cardiac irritability. In both patients the symptoms resolved after several hours, and both were later treated with clomipramine successfully and without adverse effects.1

  3. Report 3 · Study title

    Prescribing information: selegiline hydrochloride oral tablet, USP, selegiline hydrochloride oral tablet, USP

    A drug interaction was observed in a patient taking protriptyline after selegiline was added to the regimen. The patient developed tremors, agitation, and restlessness, which progressed to unresponsiveness and death.24

  4. Report 4 · Study title

    Serotonin syndrome caused by a moclobemide-clomipramine interaction

    A drug interaction occurred in a 76-year old woman who had taken clomipramine 50 mg daily for several months before being switched to moclobemide 300 mg daily. She developed somnolence, confusion, and fever, which progressed to further mental impairment, muscle stiffness, myoclonus, and convulsive attacks. Her symptoms were described as meeting the diagnostic criteria for , and they resolved a few days after all antidepressant medications were discontinued.2

  5. Report 5 · Study title

    Efficacy and adverse effects of moclobemide (letter)

    A 39-year old woman with bipolar disorder developed after imipramine was added to moclobemide. She was taking moclobemide 300 mg twice daily when imipramine was started at 50 mg daily; imipramine was then increased twice to 200 mg and moclobemide was reduced to 150 mg twice daily.

    Five days after imipramine was raised to 200 mg per day, she developed symptoms of serotonin syndrome, including sweating, shivering, confusion, fever, and spasms in the extremities. She was treated with chlorpromazine, and the symptoms resolved over the next few days without further complications.11

  6. Report 6 · Study title

    Mania induced by tricyclic-MAOI combination therapy in bipolar treatment-resistant disorder: case reports

    Three patients with bipolar disorder developed manic symptoms during concurrent treatment with isocarboxazid and amitriptyline. In all three, the and the TCA had previously been given separately without complications. Mania emerged only when the drugs were combined, which suggests a effect.12

  7. Report 7 · Study title

    Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction

    In one case, clomipramine 10 mg twice daily was added to a stable regimen of tranylcypromine in a physically healthy 34-year old man. After several doses, he developed nausea and profuse sweating, followed by pyrexia, dyspnea, and agitation. The hyperpyrexic state led to disseminated intravascular coagulation and eventually death.13

  8. Report 8 · Study title

    Experimental use of monoamine oxidase inhibitors with tricyclic antidepressants

    There is evidence that and can be given together to patients who previously did not respond to either an or a TCA alone. Several precautions should be observed: a) avoid large doses (no more than 150 mg amitriptyline or its equivalent, 45 mg phenelzine, or 60 mg isocarboxazid), b) use oral administration, c) avoid any combination of clomipramine, imipramine, desipramine, and tranylcypromine, and d) monitor patients closely.14561516

    The combination can be used in one of two ways. Most often, the recommendation is to discontinue all prior antidepressants (five to ten days for TCAs and 14 days for MAOIs) and then start both drugs at the same time.17

    Alternatively, in a patient already receiving a TCA, small doses of the MAOI may be added slowly.20 Some sources suggest that amitriptyline with isocarboxazid is the preferred combination.17 Numerous studies in patients with refractory depression or phobic anxiety states have used the combination of MAOIs and TCAs successfully.18619

Protriptyline and Clorgyline: Common Questions

How serious is the Protriptyline and Clorgyline interaction?

It is rated . These should generally not be used together.

How is the Protriptyline and Clorgyline interaction managed?

Care teams generally avoid this combination. If you are switching from one to the other, the timing matters. If moving from clorgyline to protriptyline, your team will have you wait at least 14 days after the last clorgyline dose. If moving from protriptyline to clorgyline, there is no set waiting period, but your team will likely lower the protriptyline dose gradually first. Do not stop or change… Management is individual — always follow your own care team's guidance.

Who is at higher risk from the Protriptyline and Clorgyline interaction?

The interaction record names this group as more likely to be affected:

  • People taking higher doses

If this describes you, tell your pharmacist or prescriber.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Protriptyline and Clorgyline Interaction

Ask in your own words about taking Protriptyline and Clorgyline together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (24)

  1. Insel TR, Roy BF, Cohen RM, et al: Possible development of the serotonin syndrome in man. Am J Psychiatry 1982; 139:954-955. PubMed
  2. Spigset O, Mjorndal T, & Lovheim O: Serotonin syndrome caused by a moclobemide-clomipramine interaction. Br Med J 1993; 306:248. DOI
  3. Lockett MF & Milner G: Combining the antidepressant drugs (letter). Br Med J 1965; 1:921. DOI
  4. Brachfeld J, Wirtshafter A, & Wolfe S: Imipramine-tranylcypromine incompatibility. Near fatal toxic reaction. JAMA 1963; 186:1172. DOI
  5. Winston F: Combined antidepressant therapy. Br J Psychiatry 1971; 118:301-304. DOI
  6. Schuckit M, Robins E, & Feighner JP: Tricyclic antidepressants and monoamine oxidase inhibitors. Combination therapy in the treatment of depression. Arch Gen Psychiatry 1971; 24:509-514. PubMed
  7. Sargent W: Combining the antidepressant drugs (letter). Br Med J 1965; 1:251. DOI
  8. Spiker DG & Pugh DD: Combining tricyclic and monoamine oxidase inhibitor antidepressants. Arch Gen Psychiatry 1976; 33:828-830. PubMed
  9. Sjoqvist F: Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances. Proc R Soc Med 1965; 58:967-978. DOI
  10. Sternbach H: The serotonin syndrome. Am J Psychiatr 1991; 148:705-713. PubMed
  11. Brodribb TR, Downey M, & Gilbar PJ: Efficacy and adverse effects of moclobemide (letter). Lancet 1994; 343:475. DOI
  12. de la Fuente JR, Berlanga C, & Leon-Andrade C: Mania induced by tricyclic-MAOI combination therapy in bipolar treatment-resistant disorder: case reports. J Clin Psychiatry 1986; 47:40-41.
  13. Tackley RM & Tregaskis B: Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction. Anaesthesia 1987; 42(7):760-763. PubMed
  14. Kline NS: Experimental use of monoamine oxidase inhibitors with tricyclic antidepressants. JAMA 1974; 227:807.
  15. White K & Simpson G: The combined use of MAOIs and tricyclics. J Clin Psychiatry 1984; 45:67-69.
  16. Rom WN & Benner EJ: Toxicity by interaction of tricyclic antidepressant and monoamine oxidase inhibitor. Calif Med 1972; 117:65-66.
  17. Perry PJ, Alexander B, & Liskow BIPerry PJ, Alexander B, & Liskow BI: Psychotropic Drug Handbook, 6th. Harvey Whitney Books Company, Cincinnati, OH, 1991.
  18. Ponto LB, Perry PJ, Liskow BI, et al: Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy. Am J Hosp Pharm 1977; 34:954-961. DOI
  19. Ashcroft GW: Psychological medicine: management of depression. Br Med J 1975; 2:372-376. PubMed
  20. Schoonover SC: Depression In: Bassuk EL, Schoonover SC, & Gelenberg AJ (Eds): The Practitioner's Guide to Psychoactive Drugs, 2nd. Plenum Medical Book Company, New York, NY, 1983. DOI
  21. Neuvonen PJ, Pohjola-Sintonen S, Tacke U, et al: Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses (letter). Lancet 1993; 342:1419. PubMed
  22. Product Information: VIVACTIL(R) Tablets, protriptyline hydrochloride tablets, USP. Odyssey Pharmaceuticals Inc. East Hanover, NJ, 2004. DailyMed
  23. Remick RA: Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002; 167(11):1253-60.
  24. Product Information: selegiline hydrochloride oral tablet, USP, selegiline hydrochloride oral tablet, USP. Par Pharmaceutical, Inc, Spring Valley, NY, 2003. DailyMed
Was this write-up helpful?

Other Serious Interactions of Protriptyline and Clorgyline

Also serious with Protriptyline

Also serious with Clorgyline

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Protriptyline

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks. This interaction.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.